Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN114853838B reveals a low-cost, high-yield preparation method for abiraterone acetate, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.
Novel preparation method improves purity and yield. Green chemistry approach reduces toxicity. Reliable supply chain partner for oncology APIs.
Patent CN103319311A details a high-efficiency iridium-catalyzed route for (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol, offering superior ee values and scalability for API production.
Discover a novel industrial route for Apalutamide intermediates using copper catalysis. This patent-backed method ensures high purity, safety, and cost-effective manufacturing.
Advanced patent CN107954919B reveals a green Fischer indole route for Rucaparib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Novel cyanoacetic acid route for 2-chloro-5-cyanopyrimidine. Eliminates heavy metals and phosgene. Cost-effective industrial scale-up for API manufacturing.
Discover the novel preparation of 7-hydroxy-[1,2,4]triazolo[1,5-a]pyridine via patent CN114671867A. Achieve high purity and scalable manufacturing for HER2 inhibitors.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110950872A details a high-yield Boc-protection strategy for Avapritinib, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced 4-step synthesis of Trilaciclib intermediate via mild conditions. Reduces purification costs and enhances supply chain reliability for CDK4/6 inhibitors.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN101863861A reveals efficient beta-lactam route for Larotaxel, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.